Works matching IS 14642662 AND DT 2010 AND VI 11 AND IP 8

Results: 12

Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA)

Published in:

2010

By:

Di Vincenzo P;
Rusconi S;
Adorni F;
Vitiello P;
Maggiolo F;
Francisci D;
Di Biagio A;
Monno L;
Antinori A;
Boeri E;
Punzi G;
Perno C;
Callegaro A;
Bruzzone B;
Zazzi M;
Antiretroviral Resistance Cohort Analysis (ARCA) Collaborative Group

Publication type:

Journal Article

Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD).

Published in:

2010

By:

Oyomopito R;
Lee MP;
Phanuphak P;
Lim PL;
Ditangco R;
Zhou J;
Sirisanthana T;
Chen YMA;
Pujari S;
Kumarasamy N;
Sungkanuparph S;
Lee CKC;
Kamarulzaman A;
Oka S;
Zhang FJ;
Mean CV;
Merati T;
Tau G;
Smith J;
Li PCK

Publication type:

Journal Article

Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy.

Published in:

2010

By:

Lattuada E;
Vallone A;
Lanzafame M;
Corsini F;
Concia E;
Vento S

Publication type:

Journal Article

HIV-1 proviral resistance mutations: usefulness in clinical practice.

Published in:

HIV Medicine, 2010, v. 11, n. 8, p. 483, doi. 10.1111/j.1468-1293.2009.00814.x

By:

Kabamba-Mukadi, B.;
Duquenne, A.;
Henrivaux, P.;
Musuamba, F.;
Ruelle, J.;
Yombi, J.-C.;
Bodéus, M.;
Vandercam, B.;
Goubau, P.

Publication type:

Article

No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial.

Published in:

HIV Medicine, 2010, v. 11, n. 8, p. 493, doi. 10.1111/j.1468-1293.2009.00817.x

By:

Calmy, A.;
Bloch, M.;
Wand, H.;
Delhumeau, C.;
Finlayson, R.;
Rafferty, M.;
Norris, R.;
Hirschel, B.;
Cooper, D. A.;
Carr, A.

Publication type:

Article

Sexually transmitted infections and infectiousness beliefs among people living with HIV/AIDS: implications for HIV treatment as prevention.

Published in:

HIV Medicine, 2010, v. 11, n. 8, p. 502, doi. 10.1111/j.1468-1293.2009.00818.x

By:

Kalichman, S. C.;
Eaton, L.;
Cherry, C.

Publication type:

Article

Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA).

Published in:

HIV Medicine, 2010, v. 11, n. 8, p. 530, doi. 10.1111/j.1468-1293.2009.00819.x

By:

Di Vincenzo, P.;
Rusconi, S.;
Adorni, F.;
Vitiello, P.;
Maggiolo, F.;
Francisci, D.;
Di Biagio, A.;
Monno, L.;
Antinori, A.;
Boeri, E.;
Punzi, G.;
Perno, C.-F.;
Callegaro, A.;
Bruzzone, B.;
Zazzi, M.

Publication type:

Article

HIV-associated obliterative portopathy (HIV-OP) underlies cryptogenic liver disease in HIV-seropositive patients.

Published in:

2010

By:

Mallet, V. O.;
Sultanik, P. S.;
Vallet-Pichard, A.;
Pol, S.

Publication type:

Letter

Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy.

Published in:

2010

By:

Lattuada, E.;
Vallone, A.;
Lanzafame, M.;
Corsini, F.;
Concia, E.;
Vento, S.

Publication type:

Letter

Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD).

Published in:

HIV Medicine, 2010, v. 11, n. 8, p. 519, doi. 10.1111/j.1468-1293.2010.00822.x

By:

Oyomopito, R.;
Lee, M. P.;
Phanuphak, P.;
Lim, P. L.;
Ditangco, R.;
Zhou, J.;
Sirisanthana, T.;
Chen, Y. M. A.;
Pujari, S.;
Kumarasamy, N.;
Sungkanuparph, S.;
Lee, C. K. C.;
Kamarulzaman, A.;
Oka, S.;
Zhang, F. J.;
Mean, C. V.;
Merati, T.;
Tau, G.;
Smith, J.;
Li, P. C. K.

Publication type:

Article

Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.

Published in:

HIV Medicine, 2010, v. 11, n. 8, p. 510, doi. 10.1111/j.1468-1293.2010.00825.x

By:

Hosseinipour, M. C.;
Kumwenda, J. J.;
Weigel, R.;
Brown, L. B.;
Mzinganjira, D.;
Mhango, B.;
Eron, J. J.;
Phiri, S.;
van Oosterhout, J. J.

Publication type:

Article

Effects of highly active antiretroviral therapy on vaccine-induced humoral immunity in HIV-infected adults.

Published in:

HIV Medicine, 2010, v. 11, n. 8, p. 535, doi. 10.1111/j.1468-1293.2010.00830.x

By:

González, R.;
Castro, P.;
García, F.;
Plana, M.;
Bayas, J. M.;
Lafuente, S.;
Serrano, B.;
Mora, B.;
Argelich, R.;
Gatell, J. M.;
Vilella, A.

Publication type:

Article